Treatment for neovascular age related macular degeneration: The state of the art
Author:
Publisher
Elsevier BV
Subject
Pharmacology
Reference75 articles.
1. Anti-VEGF treatment in neovascular age-related macular degeneration: a treat-and-extend protocol over 2 years;Abedi;Retina,2014
2. Intravitreal Bevacizumab (Avastin) for Neovascular age-related macular degeneration;Avery;Ophthalmology,2006
3. What is the evidence for systemic effects of Intravitreal anti-VEGF Agents, and should we be concerned?;Avery;Br. J. Ophthalmol.,2014
4. Aflibercept therapy for exudative age-related macular degeneration resistant to Bevacizumab and Ranibizumab;Bakall;Am. J. Ophthalmol.,2013
5. Ranibizumab or Bevacizumab for Neovascular age-related macular degeneration according to the Lucentis compared to Avastin study treat-and-extend protocol: two-year results;Berg;Ophthalmology,2015
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Topical Solution for Retinal Delivery: Bevacizumab and Ranibizumab Eye Drops in Anti-Aggregation Formula (AAF) in Rabbits;Pharmaceutical Research;2024-06
2. Recent Advances of Ocular Drug Delivery Systems: Prominence of Ocular Implants for Chronic Eye Diseases;Pharmaceutics;2023-06-15
3. Color Vision and Microperimetry Changes in Nonexudative Age-Related Macular Degeneration After Risuteganib Treatment: Exploratory Endpoints in a Multicenter Phase 2a Double-Masked, Randomized, Sham-Controlled, Crossover Clinical Trial;Ophthalmic Surgery, Lasers and Imaging Retina;2022-08
4. Efficacy and Safety of Biosimilar FYB201 Compared with Ranibizumab in Neovascular Age-Related Macular Degeneration;Ophthalmology;2022-01
5. Stem Cell Therapy for Retinal Degeneration: The Evidence to Date;Biologics: Targets and Therapy;2021-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3